BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2460446)

  • 1. The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
    Schmaier AH; Kuo A; Lundberg D; Murray S; Cines DB
    J Biol Chem; 1988 Nov; 263(31):16327-33. PubMed ID: 2460446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
    Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
    J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
    Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
    J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight kininogen binds to unstimulated platelets.
    Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
    J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophils contain and bind high molecular weight kininogen.
    Gustafson EJ; Schmaier AH; Wachtfogel YT; Kaufman N; Kucich U; Colman RW
    J Clin Invest; 1989 Jul; 84(1):28-35. PubMed ID: 2738152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
    Reddigari SR; Kuna P; Miragliotta G; Shibayama Y; Nishikawa K; Kaplan AP
    Blood; 1993 Mar; 81(5):1306-11. PubMed ID: 8443392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
    Zini JM; Schmaier AH; Cines DB
    Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
    Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
    Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells.
    Schmaier AH; Murray SC; Heda GD; Farber A; Kuo A; McCrae K; Cines DB
    J Biol Chem; 1989 Oct; 264(30):18173-9. PubMed ID: 2478540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High molecular weight kininogen inhibition of endothelial cell function on biomaterials.
    Voskerician G; Anderson JM; Ziats NP
    J Biomed Mater Res; 2000 Jul; 51(1):1-9. PubMed ID: 10813738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of high molecular weight kininogen to cultured human endothelial cells.
    van Iwaarden F; de Groot PG; Bouma BN
    J Biol Chem; 1988 Apr; 263(10):4698-703. PubMed ID: 2832403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
    Meloni FJ; Schmaier AH
    J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
    Hasan AA; Cines DB; Ngaiza JR; Jaffe EA; Schmaier AH
    Blood; 1995 Jun; 85(11):3134-43. PubMed ID: 7756645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells.
    Fernando LP; Fernando AN; Joseph K; Kaplan AP
    J Thromb Haemost; 2003 Nov; 1(11):2444-9. PubMed ID: 14629481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
    Hasan AA; Cines DB; Zhang J; Schmaier AH
    J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.